Coherus BioSciences to Report Second Quarter 2022 Financial Results on August 4th, 2022
Coherus BioSciences (CHRS) will release its second quarter 2022 financial results after market close on August 4, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Coherus BioSciences (CHRS) will release its second quarter 2022 financial results after market close on August 4, 2022. The management will host a conference call at 5 p.m. ET to discuss these results and provide a business update. Investors can access the results on the Coherus website post-release. The call can be joined through specific dial-in numbers provided for both U.S. and international participants. Early connection is advised for attendees.
Details
News Market Reaction – CHRS
The recorded move for CHRS in the trading session of this news was +0.36%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2022 financial results will be released after market close on Thursday, August 4th, 2022. Starting at 5 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.
After releasing second quarter 2022 financial results, the Company will post them on the Coherus website at https://investors.coherus.com.
Conference Call Information
When: Thursday, August 4th, 2022, starting at 5 p.m. ET
Dial-in: (800) 715-9871 (Toll-Free U.S. and Canada) or (646) 307-1963 (International)
Conference ID: 8699439
Webcast: https://investors.coherus.com/upcoming-events
Please dial-in 15 minutes early to ensure a timely connection to the call.
Coherus Contact Information:
Marek Ciszewski, J.D.
SVP, Investor Relations
Coherus BioSciences, Inc.
IR@coherus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.